Company intelligence / Profile preview

ImmunoVision

Springdale, Arkansas, United States
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

ImmunoVision is a specialized biotechnology company focused on the development and manufacture of reagents for autoimmune disease research and diagnostics. Established in 1987 and headquartered in Springdale, Arkansas, the company is a global leader in providing purified autoantigens, antibodies, and diagnostic kits. Their product portfolio is essential for the detection of rheumatic diseases, including Systemic Lupus Erythematosus and Sjögren's Syndrome. ImmunoVision specializes in the purification of native antigens and the production of high-quality recombinant proteins. The company serves clinical laboratories, academic researchers, and pharmaceutical companies worldwide. Currently operating as a subsidiary of Euroimmun, a Revvity company, ImmunoVision continues to set industry standards for biological reagents in the field of immunology.

Therapeutic areas
ImmunologyRheumatology
Modalities
AntibodyProteinRecombinant protein
Industry
Protein Biomarker Diagnostics

Beyond the preview

Go deeper on ImmunoVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmunoVision.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call